Sec Form 13G Filing - CONSILIUM FRONTIER EQUITY FUND LP filing for - 2026-02-02

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  (1) Consists of 4,504,241 shares of Common Stock, $0.0001 par value per share (the "Common Stock") held by CONSILIUM FRONTIER EQUITY FUND LP, a Delaware partnership. Jonathan Binder and Charles Cassel are the managing members of CONSILIUM FRONTIER EQUITY FUND LP, and have voting and investment power over the Common Stock held by CONSILIUM FRONTIER EQUITY FUND LP. (2) Based on 29,908,235 shares of Common Stock comprised of 28,350,031 shares of Common Stock of the issuer deemed to be outstanding on October 22, 2025, the closing of the issuer's business combination, plus 588,235 shares of Common Stock issued in a private placement that closed on December 23, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  (1) Consists of (a) 564,412 shares of Common Stock issued to Mr. Binder in connection with the consummation of the issuer's business combination, and (b) 4,504,241 shares of Common Stock, $0.0001 par value per share (the "Common Stock") held by CONSILIUM FRONTIER EQUITY FUND LP, a Delaware partnership. Jonathan Binder and Charles Cassel are the managing members of CONSILIUM FRONTIER EQUITY FUND LP, and have voting and investment power over the Common Stock held by CONSILIUM FRONTIER EQUITY FUND LP. (2) Based on 29,908,235 shares of Common Stock comprised of 28,350,031 shares of Common Stock of the issuer deemed to be outstanding on October 22, 2025, the closing of the issuer's business combination, plus 588,235 shares of Common Stock issued in a private placement that closed on December 23, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  (1) Consists of (a) 564,413 shares of Common Stock issued to Mr. Binder in connection with the consummation of the issuer's business combination, and (b) 4,504,241 shares of Common Stock, $0.0001 par value per share (the "Common Stock") held by CONSILIUM FRONTIER EQUITY FUND LP, a Delaware partnership. Jonathan Binder and Charles Cassel are the managing members of CONSILIUM FRONTIER EQUITY FUND LP, and have voting and investment power over the Common Stock held by CONSILIUM FRONTIER EQUITY FUND LP. (2) Based on 29,908,235 shares of Common Stock comprised of 28,350,031 shares of Common Stock of the issuer deemed to be outstanding on October 22, 2025, the closing of the issuer's business combination, plus 588,235 shares of Common Stock issued in a private placement that closed on December 23, 2025.


SCHEDULE 13G


 
CONSILIUM FRONTIER EQUITY FUND LP
 
Signature:/s/ Charles Cassel
Name/Title:Charles Cassel, Managing Member
Date:02/02/2026
 
Jonathan Binder
 
Signature:/s/ Jonathan Binder
Name/Title:Jonathan Binder
Date:02/02/2026
 
Charles Cassel
 
Signature:/s/ Charles Cassel
Name/Title:Charles Cassel
Date:02/02/2026
Exhibit Information

Exhibit 1 Joint Filing Agreement

primary_doc.xml